Photo of Elizabeth Anne Mullen,  MD

Elizabeth Anne Mullen, MD

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute
Phone: (617) 632-1938


elizabeth_mullen@dfci.harvard.edu

Elizabeth Anne Mullen, MD

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Assistant Professor, Pediatrics, Harvard Medical School
  • Staff Physician, Pediatric Oncology, Dana-Farber Cancer Institute
  • MD, Medicine, Boston Children's Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

As an academic clinician, I have developed expertise in Pediatric Renal Tumors, have regional and national leadership roles, and a strong international reputation in clinical expertise. I am the Program Leader and Institutional Disease Expert for Renal Tumors at DFCI/BCH. In this capacity, I am involved in the care and treatment plans for all patients with Renal Tumors seen at our program. I am a member of the COG Renal Tumors Steering Committee and am Chair of the Renal Tumors Biology and Classification Study, as well as the Vice-Chair for the protocol for Treatment of Very Low Risk and Standard Risk Wilms Tumor. I have responsibility for real time central review of central radiology, pathology and surgical reports of all renal tumor patients nationally (over 600 patients a year) and assignment of appropriate risk stratification to allow enrollment on appropriate therapeutic studies, a large national study which has enrolled almost 6000 patients since 2006. My interest in the improvement of outcomes in pediatric renal tumor patients has lead a study of urine proteomics to identify urinary markers of high risk renal disease. I currently chair the COG working group for the development of the next therapeutic study for patients with Favorable Histology Wilms Tumor, which will aim to incorporate additional biologic markers in risk stratification.

Publications

Powered by Harvard Catalyst
  • Sandberg JK, Mullen EA, Cajaiba MM, Smith EA, Servaes S, Perlman EJ, Geller JI, Ehrlich PF, Cost NG, Dome JS, Fernandez CV, Khanna G. Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group. Pediatr Radiol 2017. PubMed
  • Yi JS, Kamihara J, Kesselheim JC, Davies K, van Hoff J, Silverman LB, Mullen EA. Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan. Pediatr Blood Cancer 2016. PubMed
  • Gratias EJ, Dome JS, Jennings LJ, Chi YY, Tian J, Anderson J, Grundy P, Mullen EA, Geller JI, Fernandez CV, Perlman EJ. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. J Clin Oncol 2016; 34:3189-94. PubMed
  • Fernandez CV, Perlman EJ, Mullen EA, Chi YY, Hamilton TE, Gow KW, Ferrer FA, Barnhart DC, Ehrlich PF, Khanna G, Kalapurakal JA, Bocking T, Huff V, Tian J, Geller JI, Grundy PE, Anderson JR, Dome JS, Shamberger RC. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532. Ann Surg 2016. PubMed
  • Cajaiba MM, Khanna G, Smith EA, Gellert L, Chi YY, Mullen EA, Hill DA, Geller JI, Dome JS, Perlman EJ. Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations. Hum Pathol 2016; 48:81-7. PubMed
  • Dome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, Van den Heuvel-Eibrink M, Pritchard-Jones K. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. J Clin Oncol 2015; 33:2999-3007. PubMed
  • Geller JI, Ehrlich PF, Cost NG, Khanna G, Mullen EA, Gratias EJ, Naranjo A, Dome JS, Perlman EJ. Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2. Cancer 2015; 121:2457-64. PubMed
  • Servaes S, Khanna G, Naranjo A, Geller JI, Ehrlich PF, Gow KW, Perlman EJ, Dome JS, Gratias E, Mullen EA. Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group. Pediatr Radiol 2015; 45:166-72. PubMed